Volume | 659,086 |
|
|||||
News | - | ||||||
Day High | 0.33 | Low High |
|||||
Day Low | 0.2601 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
180 Life Sciences Corporation | ATNF | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.263 | 0.2601 | 0.33 | 0.283 | 0.271 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,737 | 659,086 | $ 0.2811914 | $ 185,329 | - | 0.16061 - 7.1499 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:32 | 78 | $ 0.283 | USD |
180 Life Sciences Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.17M | 7.48M | - | 0 | -38.73M | -5.18 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
180 Life Sciences News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATNF Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.3441 | 0.3754 | 0.258 | 0.2921282 | 3,197,807 | -0.0516 | -15.0% |
1 Month | 0.45 | 0.486 | 0.258 | 0.3143135 | 1,025,228 | -0.1575 | -35.0% |
3 Months | 0.6063 | 0.8272 | 0.258 | 0.3596716 | 388,122 | -0.3138 | -51.76% |
6 Months | 1.12 | 1.37 | 0.258 | 0.5994807 | 352,795 | -0.8275 | -73.88% |
1 Year | 0.41 | 7.1499 | 0.16061 | 3.02 | 1,379,825 | -0.1175 | -28.66% |
3 Years | 2.90 | 13.0453 | 0.16061 | 4.57 | 1,047,418 | -2.61 | -89.91% |
5 Years | 10.14 | 13.0453 | 0.16061 | 4.60 | 778,301 | -9.85 | -97.12% |
180 Life Sciences Description
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics. |